Combined effects of EGCG and retinol on viability and apoptosis-related gene expression in Caco-2 and HCT-116 colon cancer cells

Articles in Press

Document Type : Original Article

Authors

1 Department of Biochemistry, NT. C., Islamic Azad University, Tehran, Iran

2 Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran

10.22038/ijbms.2026.92570.19990

Abstract

Objective(s): Colorectal cancer remains a leading cause of cancer-related deaths worldwide, emphasizing the need for novel therapeutic strategies. Epigallocatechin-3-gallate (EGCG), a major green tea polyphenol, and retinol, a vitamin A derivative with antioxidant properties, have shown anti-cancer activity individually. This study investigates the combined effects of EGCG and retinol on human colorectal cancer cell lines, Caco-2 and HCT-116.
Materials and Methods: Cytotoxic effects of EGCG and retinol, alone and in combination, were evaluated using resazurin-based cell viability assays. Intracellular reactive oxygen species (ROS) levels were measured by DCFDA assay to assess antioxidant activity. Changes in expression of apoptosis- and survival-related genes (p53, p21, AKT, and NF-κB) were analyzed using quantitative real-time PCR (RT-qPCR).
Results: Combined treatment with EGCG and retinol reduced cell viability and intracellular ROS levels in both Caco-2 and HCT-116 cells. This treatment also modulated gene expression by increasing pro-apoptotic markers (p53 and p21) and decreasing anti-apoptotic markers (AKT and NF-κB), suggesting enhanced regulation of apoptosis-related pathways and inhibition of survival signaling.
Conclusion: The combined effects of EGCG and retinol result in enhanced cytotoxicity, antioxidant activity, and modulation of apoptosis- and survival-related genes in colorectal cancer cells, supporting their potential as a combined therapeutic approach. Further studies are required to confirm these findings and explore clinical relevance.

Keywords

Main Subjects

References

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7–30.
2.    Dekker E, Tanis PJ, Vleugels JL, Kasi PM, Wallace M. Pure-amc. Lancet 2019; 394: 1467–1480.
3.    Ahmed ZS, Khan E, Elias N, Elshebiny A, Dou Q. Updated review on natural polyphenols: molecular mechanisms, biological effects, and clinical applications for cancer management. Biomolecules 2025; 15: 629.
4.    Yang M, Wu X, He Y, Li X, Yang L, Song T, et al. EGCG oxidationderived polymers induce apoptosis in digestive tract cancer cells via regulating the renin–angiotensin system. Food Funct 2024; 15: 2052–2063.
5.    Shabana SM, Neamatallah M, Said MM, Othman AI, Ammar OA, Amer MA, et al. Encapsulating epigallocatechin3gallate (EGCG) in chitosan nanoparticles influenced multiple genes controlling oncostatic signalling pathways in HepG2 cells. Rev Bras Farmacogn 2024; 34: 831–842.
6.    Wu W, Gou H, Xiang B, Geng R, Dong J, Yang X, et al. EGCG enhances the chemosensitivity of colorectal cancer to irinotecan through GRP78mediated endoplasmic reticulum stress. J Oncol 2022; 7099589.
7.    Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr 2004; 24: 201–221.
8.    Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001; 1: 181–193.
9.    Wester RA, van Voorthuijsen L, Neikes HK, Dijkstra JJ, Lamers LA, Frölich S, et al.  Retinoic acid signaling drives differentiation toward the absorptive lineage in colorectal cancer. Iscience 2021; 24.
10.    LópezGómez L, Uranga JA. Polyphenols in the prevention and treatment of colorectal cancer: a systematic review of clinical evidence. Nutr 2024; 16: 2735.
11.    Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 1983; 47: 323–330.
12.    Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 2002; 23: 2063-2080.
13.    Wu YR, Choi HJ, Kang YG, Kim JK, Shin JW. In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano-and microscale particles. Int J Nanomed 2017; 7007-7013.
14.    O’Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267: 5421–5426.
15.    Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 2005; 39: 1290.
16.    Bustin SA, Vandesompele J, Pfaffl M. Standardization of qPCR and RT-qPCR. Gen Eng Biotechnol News 2009; 29:1-4.
17.    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 2001; 25: 402–408.
18.    Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27–55.
19.    Shankar S, Ganapathy S, Srivastava RK. Green tea polyphenols: Biology and therapeutic implications in cancer. Front Biosci 2007; 12: 99.
20.    Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 2011; 53: 155.
21.    Napoli JL. Physiological insights into all-trans-retinoic acid biosynthesis. Biochim Biophys Acta 2012; 1821: 152–167.
22.    Ly BT, Chi HT. Combined effect of (-)-epigallocatechin-3-gallate and all-trans retinoic acid in FLT3-mutated cell lines. Biomed Rep 2020; 13: 25.
23.    Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275–283.
24.    Hemmings BA, Restuccia DF. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 2012; 4: a011189.
25.    Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012; 26: 203–234.
26.    Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 2011; 21: 103–115.
27.    Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liaison in cancer cells. Cell Death Dis 2016; 7: e2253.
28.    Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413–431.
29.    Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579–591.
30.    Li D, Cao D, Sun Y, Cui Y, Zhang Y, Jiang J, et al. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy. Front Immunol 2024; 15: 1331641.
 
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 06 May 2026

Files

Share

How to cite

Statistics